Sanofi Consumer Healthcare India Posts Strong Q1 Growth with 33% Revenue Expansion

Sanofi Consumer Healthcare India Limited has announced robust financial performance for the first quarter of FY2026, with revenue reaching ₹2,292 million and net profit climbing to ₹678 million.

The quarter saw the company's top line expand by 33% compared to the same period last year, while profit after tax surged 36% year-on-year. Domestic operations contributed meaningfully to this growth, expanding by 15.5%, buoyed by the market reintroduction of products that had been previously recalled.

According to Himanshu Bakshi, Managing Director of the company, the results underscore the organisation's ability to execute strategically across its operational footprint. "Our performance this quarter reflects consistent, disciplined execution across our key markets. Domestic business outpaced the market, delivering both market share gains and volume growth, while exports made a meaningful contribution to overall results. Guided by science and driven by purpose, we remain committed to simplifying self‑care and making it more accessible and effective for consumers," he stated.

The company's stock trades on both the BSE (BSE:544250) and NSE (NSE: SANOFICONR) exchanges.